AAAAAA
Results: 1-25/41
Authors:
WETZEL H
GRUNDER G
HILLERT A
PHILIPP M
GATTAZ WF
SAUER H
ADLER G
SCHRODER J
REIN W
BENKERT O
Citation: H. Wetzel et al., AMISULPRIDE VERSUS FLUPENTIXOL IN SCHIZOPHRENIA WITH PREDOMINANTLY POSITIVE SYMPTOMATOLOGY - A DOUBLE-BLIND CONTROLLED-STUDY COMPARING A SELECTIVE D-2-LIKE ANTAGONIST TO A MIXED D-1- D-2-LIKE ANTAGONIST/, Psychopharmacology, 137(3), 1998, pp. 223-232
Authors:
MULLER WE
ECKERT GP
SCHEUER K
CAIRNS NJ
MARAS A
GATTAZ WF
Citation: We. Muller et al., EFFECTS OF BETA-AMYLOID PEPTIDES ON THE FLUIDITY OF MEMBRANES FROM FRONTAL AND PARIETAL LOBES OF HUMAN BRAIN - HIGH POTENCIES OF A-BETA-1-42 AND A-BETA-1-43, AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 5(1), 1998, pp. 10-15
Authors:
HAFNER H
ANDERHEIDEN W
BEHRENS S
GATTAZ WF
HAMBRECHT M
LOFFLER W
MAURER K
MUNKJORGENSEN P
NOWOTNY B
RIECHERROSSLER A
STEIN A
Citation: H. Hafner et al., CAUSES AND CONSEQUENCES OF THE GENDER DIFFERENCE IN AGE AT ONSET OF SCHIZOPHRENIA, Schizophrenia bulletin, 24(1), 1998, pp. 99-113
Authors:
DYKIEREK P
STADTMULLER G
SCHRAMM P
BAHRO M
VANCALKER D
BRAUS DF
STEIGLEIDER P
LOW H
HOHAGEN F
GATTAZ WF
BERGER M
RIEMANN D
Citation: P. Dykierek et al., THE VALUE OF REM-SLEEP PARAMETERS IN DIFFERENTIATING ALZHEIMERS-DISEASE FROM OLD-AGE DEPRESSION AND NORMAL AGING, Journal of Psychiatric Research, 32(1), 1998, pp. 1-9
Authors:
ECKERT GP
MARAS A
GATTAZ WF
CAIRNS NJ
MULLER WE
Citation: Gp. Eckert et al., CHOLESTEROL MODULATES BETA-AMYLOID EFFECTS ON HUMAN BRAIN MEMBRANES -SPECIFIC CHANGES IN ALZHEIMERS-DISEASE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 342-342
Authors:
SCHEUER K
MARAS A
GATTAZ WF
CAIRNS N
FORSTL H
MULLER WE
Citation: K. Scheuer et al., CORTICAL NMDA RECEPTOR PROPERTIES AND MEMBRANE FLUIDITY ARE ALTERED IN ALZHEIMERS-DISEASE, Dementia, 7(4), 1996, pp. 210-214
Authors:
GATTAZ WF
BRUNNER J
Citation: Wf. Gattaz et J. Brunner, PHOSPHOLIPASE A(2) AND THE HYPOFRONTALITY HYPOTHESIS OF SCHIZOPHRENIA, Prostaglandins, leukotrienes and essential fatty acids, 55(1-2), 1996, pp. 109-113
Authors:
GATTAZ WF
CAIRNS NJ
LEVY R
FORSTL H
BRAUS DF
MARAS A
Citation: Wf. Gattaz et al., DECREASED PHOSPHOLIPASE A(2) ACTIVITY IN THE BRAIN AND IN PLATELETS OF PATIENTS WITH ALZHEIMERS-DISEASE, European archives of psychiatry and clinical neuroscience, 246(3), 1996, pp. 129-131
Authors:
NILSSON FM
HANSEN BL
BUCHEL C
GATTAZ WF
GERLACH J
Citation: Fm. Nilsson et al., DIGITAL MOVEMENT ANALYSIS, A NEW OBJECTIVE METHOD OF MEASURING TARDIVE-DYSKINESIA AND DRUG-INDUCED PARKINSONIAN TREMOR - ACCEPTABILITY, RELIABILITY AND VALIDITY, European archives of psychiatry and clinical neuroscience, 246(2), 1996, pp. 71-77
Authors:
GATTAZ WF
BRUNNER J
Citation: Wf. Gattaz et J. Brunner, PHOSPHOLIPASE A(2) AND HYPOFRONTALITY IN SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, p.
Authors:
GATTAZ WF
LEVY R
CAIRNS NJ
FORSTL H
BRAUS DF
MARAS A
Citation: Wf. Gattaz et al., ALTERATION OF THE METABOLISM OF MEMBRANE PHOSPHOLIPIDS IN ALZHEIMERS-DISEASE, Fortschritte der Neurologie, Psychiatrie, 64(1), 1996, pp. 8-12
Authors:
SCHMITT A
PETROIANU G
TOOMES M
GATTAZ WF
RUFER R
Citation: A. Schmitt et al., DECREASED PLA(2)-ACTIVITY IN PLATELETS OF PARAOXONE POISONED MINI PIGS, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 114-114
Authors:
SCHMITT A
PETROIANU G
GATTAZ WF
RUFER R
Citation: A. Schmitt et al., DECREASED PLA(2)-ACTIVITY IN PLATELETS OF PARAXONE POISONED MINI PIGS., Clinical pharmacology and therapeutics, 59(2), 1996, pp. 23-23
Authors:
BUCHEL C
DELEON J
SIMPSON GM
GATTAZ WF
Citation: C. Buchel et al., ORAL TARDIVE-DYSKINESIA - VALIDATION OF A MEASURING DEVICE USING DIGITAL IMAGE-PROCESSING, Psychopharmacology, 117(2), 1995, pp. 162-165
Authors:
HEWER W
ROST W
GATTAZ WF
Citation: W. Hewer et al., CARDIOVASCULAR EFFECTS OF FLUVOXAMINE AND MAPROTILINE IN DEPRESSED-PATIENTS, European archives of psychiatry and clinical neuroscience, 246(1), 1995, pp. 1-6
Authors:
BRUNNER J
GATTAZ WF
Citation: J. Brunner et Wf. Gattaz, INTRACEREBRAL INJECTION OF PHOSPHOLIPASE A(2) INHIBITS DOPAMINE-MEDIATED BEHAVIOR IN RATS - POSSIBLE IMPLICATIONS FOR SCHIZOPHRENIA, European archives of psychiatry and clinical neuroscience, 246(1), 1995, pp. 13-16
Authors:
GATTAZ WF
SCHMITT A
MARAS A
Citation: Wf. Gattaz et al., INCREASED PLATELET PHOSPHOLIPASE A(2) ACTIVITY IN SCHIZOPHRENIA, Schizophrenia research, 16(1), 1995, pp. 1-6
Authors:
GATTAZ WF
VOGEL P
KICK H
KOHNEN R
Citation: Wf. Gattaz et al., MOCLOBEMIDE VERSUS FLUOXETINE IN THE TREATMENT OF IN PATIENTS WITH MAJOR DEPRESSION, Journal of clinical psychopharmacology, 15(4), 1995, pp. 35-40
Authors:
BRUNNER J
GATTAZ WF
Citation: J. Brunner et Wf. Gattaz, INTRACEREBROVENTRICULAR INJECTION OF PHOSPHOLIPASE A(2) INHIBITS APOMORPHINE-INDUCED LOCOMOTION IN RATS, Psychiatry research, 58(2), 1995, pp. 165-169
Authors:
HAFNER H
GATTAZ WF
Citation: H. Hafner et Wf. Gattaz, SEXUAL DIFFERENCES IN SCHIZOPHRENIA, Der Gynakologe, 28(6), 1995, pp. 426-433
Authors:
GATTAZ WF
Citation: Wf. Gattaz, DOES VITAMIN-E PREVENT TARDIVE-DYSKINESIA, Biological psychiatry, 37(12), 1995, pp. 896-897
Authors:
GATTAZ WF
MARAS A
CAIRNS NJ
LEVY R
FORSTL H
Citation: Wf. Gattaz et al., DECREASED PHOSPHOLIPASE A(2) ACTIVITY IN ALZHEIMER BRAINS, Biological psychiatry, 37(1), 1995, pp. 13-17
Authors:
DALGALARRONDO P
GATTAZ WF
Citation: P. Dalgalarrondo et Wf. Gattaz, BASAL GANGLIA ABNORMALITIES IN TARDIVE-DYSKINESIA - POSSIBLE RELATIONSHIP WITH DURATION OF NEUROLEPTIC TREATMENT, European archives of psychiatry and clinical neuroscience, 244(5), 1994, pp. 272-277
Authors:
GATTAZ WF
STEUDLE A
MARAS A
BRUNNER J
Citation: Wf. Gattaz et al., ACCELERATED BREAKDOWN OF PLATELET MEMBRANE PHOSPHOLIPIDS IN SCHIZOPHRENIA, Schizophrenia research, 11(2), 1994, pp. 122-122
Authors:
STEUDLE A
MARAS A
GATTAZ WF
Citation: A. Steudle et al., PLATELET MEMBRANE PHOSPHOLIPIDS IN SCHIZOPHRENIA, Schizophrenia research, 11(2), 1994, pp. 123-124